4dmedical Stock Current Valuation
| 4DX Stock | 0.46 0.01 2.22% |
Valuation analysis of 4Dmedical helps investors to measure 4Dmedical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Begin Period Cash Flow is likely to gain to about 73.1 M in 2024, whereas Cash is likely to drop slightly above 27.1 M in 2024. Fundamental drivers impacting 4Dmedical's valuation include:
Price Book 2.6695 | Enterprise Value 163.9 M | Enterprise Value Ebitda (7.29) | Price Sales 50.4325 | Enterprise Value Revenue 53.7276 |
Overvalued
Today
Please note that 4Dmedical's price fluctuation is out of control at this time. Calculation of the real value of 4Dmedical is based on 3 months time horizon. Increasing 4Dmedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
4Dmedical's intrinsic value may or may not be the same as its current market price of 0.46, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.46 | Real 0.41 | Hype 0.45 |
The intrinsic value of 4Dmedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence 4Dmedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of 4Dmedical helps investors to forecast how 4Dmedical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of 4Dmedical more accurately as focusing exclusively on 4Dmedical's fundamentals will not take into account other important factors: 4Dmedical Company Current Valuation Analysis
4Dmedical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current 4Dmedical Current Valuation | 163.85 M |
Most of 4Dmedical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 4Dmedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, 4Dmedical has a Current Valuation of 163.85 M. This is 98.86% lower than that of the Health Care Equipment & Supplies sector and 98.68% lower than that of the Health Care industry. The current valuation for all Australia stocks is 99.01% higher than that of the company.
4Dmedical Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 4Dmedical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 4Dmedical could also be used in its relative valuation, which is a method of valuing 4Dmedical by comparing valuation metrics of similar companies.4Dmedical is currently under evaluation in current valuation category among its peers.
4Dmedical Fundamentals
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.27 | ||||
| Operating Margin | (7.55) % | ||||
| Current Valuation | 163.85 M | ||||
| Shares Outstanding | 411.6 M | ||||
| Shares Owned By Insiders | 21.96 % | ||||
| Shares Owned By Institutions | 5.64 % | ||||
| Price To Book | 2.67 X | ||||
| Price To Sales | 50.43 X | ||||
| Revenue | 3.75 M | ||||
| Gross Profit | 684.43 K | ||||
| EBITDA | (31.86 M) | ||||
| Net Income | (35.98 M) | ||||
| Total Debt | 5.12 M | ||||
| Book Value Per Share | 0.17 X | ||||
| Cash Flow From Operations | (30.87 M) | ||||
| Earnings Per Share | (0.10) X | ||||
| Target Price | 0.9 | ||||
| Number Of Employees | 145 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 189.34 M | ||||
| Total Asset | 120.02 M | ||||
| Retained Earnings | (152.04 M) | ||||
| Working Capital | 17.16 M | ||||
| Net Asset | 120.02 M |
About 4Dmedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 4Dmedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 4Dmedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 4Dmedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 4Dmedical Stock Analysis
When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.